UNH vs ELV — which stock performed better?

UnitedHealth (UNH) versus Elevance Health (ELV), Health Care, on 2026-11-18.

Result

Elevance Health (ELV) performed better on 2026-11-18. UNH moved -9.620%, ELV moved -7.140%.

Why these two companies

On November 16, 2026, CMS proposed its new CRUSH rule expanding Medicare Advantage fraud audits, and UnitedHealth, the largest Medicare Advantage insurer, led a sector-wide selloff with shares down roughly 5% on November 17 while more diversified peer Elevance Health fell by a much smaller amount. The same regulatory shock hitting two very differently sized and structured managed-care companies, with UnitedHealth sitting far below its 52-week high while Elevance sits right near its own, makes for a timely real-world test of scale versus diversification. Both stocks remain squarely in the middle of an active investor debate over how much the new audit rule will actually cost insurers.

The research

UnitedHealth is a giant health insurer that also owns Optum, a huge pharmacy and medical-services business, together covering people through private Medicare plans, workplace insurance and Medicaid. Elevance Health, previously known as Anthem, runs Blue Cross Blue Shield health plans in more than a dozen states along with a growing services arm called Carelon, and it is roughly a quarter the size of UnitedHealth by overall company value.

One reason to look at UnitedHealth is that new federal rules targeting Medicare fraud just hit its stock hard because it is the single biggest player in that market, and shares are now sitting well below their highest point of the past year, which some investors see as an opportunity. One reason to look at Elevance is that its business is spread more evenly across different types of health plans, so it barely flinched on the same news and is still trading right near its own high point for the year.

Something to keep in mind with UnitedHealth is that new government rules aimed at insurers can take years to actually show up in a company's results, so a sharp one-day stock move may say more about investor nerves than about real future profits. Something to keep in mind with Elevance is that it faces many of the same government rules and a separate legal dispute over its own Medicare plan ratings, so its calmer reaction this week does not mean it is free of the same risks.